Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
1.061
-0.049 (-4.45%)
Nov 5, 2025, 11:58 AM EST - Market open
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $95.14 million as of November 5, 2025. Its market cap has decreased by -37.82% in one year.
Market Cap
95.14M
Enterprise Value
16.22M
1-Year Change
-37.82%
Ranking
Category
Stock Price
$1.06
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $95.14M, an increase of 86.45%. That is a compound annual growth rate of 16.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 99.57M | 5.71% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 798.09B |
| Johnson & Johnson | 450.30B |
| AbbVie | 375.22B |
| UnitedHealth Group | 301.13B |
| AstraZeneca | 253.98B |
| Novartis AG | 237.13B |
| Novo Nordisk | 216.87B |
| Abbott Laboratories | 213.59B |